Related Experiment Video
Updated: Jul 5, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Basic HIV vaccine development
1Department of Pathology, AIDS Vaccine Research Laboratory, University of Wisconsin Madison, Madison, WI, USA.
Abstract:
The highlight of the 2008 Conference on Retroviruses and Opportunistic Infections was a sober assessment of the HIV vaccine field by one of its pioneers. Desrosiers delivered a plenary session in which he called for refocusing our HIV vaccine effort. He suggested that none of the current vaccine candidates in human clinical trials stands a chance against HIV. Thus, we need to redirect our efforts to basic vaccine research. This call for a sea change in how we carry out HIV vaccine research has already had an impact, prompting a recent HIV vaccine summit in Bethesda, MD. This will likely herald a new era in HIV vaccine research, resulting in a redoubling of effort to uncover innovative new ways of making an HIV vaccine.
Related Concept Videos
Vaccine Production
Retroviruses
Inhibitors of Virion Maturation and Assembly
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Retrovirus Life Cycles

